Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Macmillan Cancer Support

UK company 02400969, incorporated on 30 June 1989.

My Care Plan

Macmillan Cancer Support is a UK company with status Active founded in 1989 based in London.

Company number

02400969

Incorporated

30 Jun 1989

Companies House status

Active

Company identity

Founded / incorporated

30 June 1989

Company number 02400969

Verify at Companies House

Legal name

MACMILLAN CANCER SUPPORT

Company type

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)

Region

London

Registered address

3RD FLOOR BRONZE BUILDING, THE FORGE

105 SUMNER STREET

LONDON

ENGLAND

SE1 9HZ

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 3

Macmillan Cancer Support

No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

5 events

31 Jul

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep

2026

Accounts due

Accounts Due

Next accounts due date

17 Jul

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2024

Accounts filed

Accounts

Last accounts made up date

30 Jun

1989

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2023

Funded years

2023

Age at first award

33 years

Projects

2023 Collaborative R&D

Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis

1 Jan 2023 to 30 Sep 2024

Awarded

£23,818

Total cost £23,818

Neutropenic sepsis (NS) is a life-threatening complication of cancer chemotherapy. It occurs because chemotherapy temporarily suppresses the immune system, particularly neutrophil cells, and even mild illnesses can be fatal for patients during this time. As a result, if any chemotherapy patient has a fever or feels unwell they are advised to attend hospit...

Product types

Collaborative R&D